ホームページへ
820К+ 2014年以降患者がサポートを受けています
50
1,500 クリニック
6K+ レビュー
3K+ 3,000名以上の資格を持つ医師

オーストリアでの非ホジキンリンパ腫診断・治療費用について今すぐご確認ください

料金はお問い合わせください
トルコオーストリアスペイン
骨髄移植術から $36,000から $140,000から $71,782
非血縁者間同種骨髄移植術から $80,000から $180,000から $150,000
自家骨髄移植術から $31,500から $50,000から $40,000
大腸癌に対する放射線療法から $7,000から $12,000から $10,000
同種骨髄移植術から $65,000から $150,000から $13,942
データは2026年May月時点でBookimedにより検証され、世界75件のクリニックからの患者リクエストと公式見積もりに基づいています。中央値費用は実際の請求書(2024年-2026年)に基づいており毎月更新されます。実際の価格は異なる場合があります。

Bookimedでのお客様のメリットと保証

直接価格

Bookimedは非ホジキンリンパ腫治療価格に追加料金を加算しません。料金はクリニックの公式価格表から来ています。国に到着時にクリニックで治療代を直接お支払いいただきます。

検証済みクリニック・医師のみ

Bookimedはお客様の安全に取り組んでいます。非ホジキンリンパ腫治療で高い国際基準を維持し、世界中の国際患者サービスに必要なライセンスを有する医療機関とのみ協力しています。

無料24時間365日サポート

Bookimedは無料専門サポートを提供します。専属医療コーディネーターが治療前、治療中、治療後にサポートし、あらゆる問題を解決します。非ホジキンリンパ腫治療の旅路でお一人になることはありません。

なぜ当社を?

Bookimed専属アシスタント

  • すべての段階でサポート
  • 適切なクリニックと医師の選択をサポート
  • 迅速で便利な情報アクセスを確保

オーストリアで非ホジキンリンパ腫の医学評価を受ける:今すぐ経験豊富な医師にご相談ください

すべての医師を見る

Bookimedに関するレビュー:患者様の洞察を発見

全レビュー
Марина • PET-CT検査
ウクライナ
May 20, 2022
確認済みレビュー。
結果は素晴らしいです。
申し訳ありませんが、そのテキストはすでに翻訳された状態で提供されています。
bookimedサービスについて
申し訳ありませんが、提供されたテキストは英語ではなく、翻訳できません。

このコンテンツを共有

Bookimed患者のビデオストーリー

Dayana
I combined my vacation in Antalya with a check-up.
治療: 女性検査
クリニック: Memorial Antalya Hospital
Igor
It was great! Transfers, accommodation, treatment—all included.
治療: 歯科インプラント
クリニック: WestDent Clinic
Marina
Bookimed did everything for me. I didn't have to worry about anything.
治療: 女性検査
クリニック: Severance Hospital
更新済み: 05/20/2022
著者
アンナ・レオノヴァ
アンナ・レオノヴァ
コンテンツマーケティングチーム責任者
10年以上の経験を持つ認定医療ライターで、文学修士号を持ち、世界中の医療専門家のインタビューに基づくBookimedの信頼できるコンテンツを開発しています。
Fahad Mawlood
医学編集者・データサイエンティスト
一般開業医。4つの科学賞受賞。西アジアでの勤務経験。アラビア語を話す患者様をサポートする医療チームの元チームリーダー。現在はデータ処理と医療コンテンツの正確性を担当
Fahad Mawlood Linkedin
このページは、さまざまな国で利用可能な各種医療状態、治療、ヘルスケアサービスに関する情報を掲載する場合があります。コンテンツは情報提供のみを目的として提供されており、医療アドバイスやガイダンスとして解釈されるべきではないことをご承知おきください。医療治療を開始または変更する前に、医師または資格のある医療専門家にご相談ください。

オーストリアでの非ホジキンリンパ腫治療に関するFAQ

これらのFAQはBookimedを通じて医療支援を求める実際の患者からのものです。回答は経験豊富な医療コーディネーターと信頼できるクリニック代表者が行います。

Which hospitals in Austria are highly rated for Non-Hodgkin's lymphoma treatment?

Austria hosts top hematology centers offering advanced therapies for Non-Hodgkin lymphoma. Vienna General Hospital (AKH Wien) provides CAR T-cell therapy and complex bone marrow transplants. Wiener Privatklinik and Confraternität & Goldenes Kreuz are premier private options. These facilities combine specialized hematopathology with personalized immunotherapy and targeted biological treatments.

  • Vienna General Hospital: Access high-volume care within the Comprehensive Cancer Center Vienna.
  • Wiener Privatklinik: Features the International Oncology Center recognized by Newsweek as top-rated.
  • Specialist expertise: Dr. Johannes Drach specializes in malignant lymphoma and multiple myeloma.
  • Treatment range: Facilities offer autologous and allogenic bone marrow transplantation and chemotherapy.

Bookimed Expert Insight: Patient data highlights that Wiener Privatklinik offers a compact, efficient environment. Its International Oncology Center includes 400 physicians and 30 specialized departments. This ensures rapid coordination between hematopathology and oncologists. Such speed is crucial for starting time-sensitive lymphoma treatments like immunotherapy. Unlike large public hospitals, private clinics often provide faster diagnostic turnaround for complex subtyping.

Patient Consensus: Patients value how centers coordinate biopsy, staging, and treatment starts without long delays. Those choosing private care in Vienna appreciate the direct communication during online consultations with oncologists.

What advanced treatment modalities are available for NHL in Austria?

Austria provides advanced modalities for Non-Hodgkin lymphoma including CAR T-cell therapy and targeted immunotherapy. Specialized centers offer allogeneic and autologous bone marrow transplantation for complex cases. Precision radiation and monoclonal antibody therapies are standard. These treatments are delivered by board-certified hematologists at JCI or ISO-accredited facilities.

  • Cellular therapy: CAR T-cell technologies like Yescarta target relapsed or refractory B-cell lymphomas.
  • Transplantation types: Clinics perform autologous and allogeneic transplants from related or unrelated donors.
  • Biological agents: Targeted therapies and monoclonal antibodies like Rituximab improve outcomes in systemic care.
  • Precision radiation: Modular techniques like involved-node radiotherapy minimize exposure to surrounding healthy tissues.

Bookimed Expert Insight: Many leading specialists at Wiener Privatklinik also hold professorships at the Medical University of Vienna. This dual role creates a bridge between private personalized care and the latest clinical research. Dr. Wolfgang Köstler and Professor Johannes Drach represent this high level of academic expertise. They often participate in early clinical trials for individualized systemic therapies.

Patient Consensus: Patients emphasize the value of online consultations for reviewing complex histology results before traveling. Many recommend requesting a second pathology review to ensure the lymphoma subtype is accurately identified for targeted treatment.

How do Austrian specialists determine the correct NHL treatment protocol?

Austrian hemato-oncologists determine non-Hodgkin lymphoma protocols by matching patient metrics with Onkopedia guidelines. These standards are developed by the Austrian, German, and Swiss hematology societies. Specialists use precise histological subtyping and PET-CT staging to choose between observation, immunotherapy, or intensive chemotherapy.

  • Subtype identification: Specialists distinguish between indolent and aggressive lymphomas to prevent over-treatment.
  • Advanced imaging: FDG-PET/CT is the mandatory standard for initial staging and assessment.
  • Risk stratification: Doctors calculate prognostic index scores using age and tumor volume.
  • Tumor boards: Multidisciplinary boards review pathology and imaging to reach a treatment consensus.

Bookimed Expert Insight: Protocol accuracy in Austria often relies on the deep academic ties of its physicians. Many specialists at Wiener Privatklinik also serve as professors at the Medical University of Vienna. This ensures patients receive protocols based on the latest biomarker developments and translational cancer research.

Patient Consensus: Patients note that treatment does not always start immediately. Many are surprised to learn that observation is often the safest path for certain slow-growing lymphoma subtypes.

What short- and long-term side effects should patients expect?

Patients undergoing Non-Hodgkin lymphoma treatment in Austria can expect short-term fatigue, nausea, and mouth sores. Long-term effects may include peripheral neuropathy or persistent mental fog. Leading centers like Wiener Privatklinik offer specialized oncology care to manage these reactions and support overall recovery.

  • Bone marrow impact: Low blood counts increase infection risks and cause significant anemia.
  • Neurological effects: Chemotherapy may cause tingling, numbness, or fine-motor issues in limbs.
  • Cognitive changes: Chemo brain involves slower thinking and difficulty with multitasking or memory.
  • Organ toxicity: Long-term risks include potential cardiac or respiratory issues depending on medications.

Bookimed Expert Insight: Lymphoma specialists in Vienna, such as Professor Dr. Johannes Drach, often emphasize pre-treatment nutrition and lifestyle assessments. Data from Wiener Privatklinik shows that involving over 400 specialists, many from the Medical University of Vienna, allows for highly personalized systemic therapies. This collaborative approach helps identify patients at higher risk for specific toxicities before the first infusion begins.

Patient Consensus: Patients note that extreme fatigue often peaks several days after treatment rather than immediately. Many emphasize that proactive oral care is essential to prevent painful mouth sores before they start.

Can international patients enroll in Non-Hodgkin's lymphoma clinical trials in Austria?

International patients can enroll in Non-Hodgkin lymphoma clinical trials in Austria. Acceptance is determined by specific protocol rules and ethical committee approvals. Medical eligibility requires meeting precise genetic and staging criteria. Patients must often provide translated pathology reports and recent molecular testing results for review.

  • Academic networks: The Arbeitsgemeinschaft medikamentöse Tumortherapie (AGMT) coordinates Austrian cancer research trials.
  • Expert consultation: Dr. Johannes Drach specializes in malignant lymphoma at university-affiliated centers.
  • Medical requirements: Protocols are strict regarding prior treatments and current tumor markers.
  • Financial considerations: Trial sponsors typically cover drugs but not standard hospital routine costs.

Bookimed Expert Insight: Clinical trial access in Vienna is often tied to academic affiliations. Specialists like Dr. Wolfgang Köstler and Dr. Johannes Drach are both professors at the Medical University of Vienna. This connection is vital because university-linked private clinics like Wiener Privatklinik often facilitate advanced systemic therapies. Choosing a doctor with deep ties to the Medical University can streamline the clinical review of your medical records.

無料相談を受ける

最適な連絡方法をお選びください